drugset / Trial / NCT03667313

Treatment of In-Stent Restenosis 2 Study

NCT03667313

Phase 3 Completed 200 enrolled University Hospital Ostrava
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to compare the efficacy of sirolimus-eluting balloon catheters (SEB) and iopromide-coated paclutaxel-eluting balloon catheters (PEB) in the treatment of bare metal (BMS) - or drug-eluting stents restenosis (DES-ISR).

Timeline

Start
2018-10-01
Primary completion
2021-11-30
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule
Subject Sirolimus Small molecule

Indications